Feng Shen

18.7k total citations · 4 hit papers
299 papers, 10.1k citations indexed

About

Feng Shen is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, Feng Shen has authored 299 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Surgery, 123 papers in Hepatology and 103 papers in Oncology. Recurrent topics in Feng Shen's work include Cholangiocarcinoma and Gallbladder Cancer Studies (144 papers), Hepatocellular Carcinoma Treatment and Prognosis (120 papers) and Gallbladder and Bile Duct Disorders (76 papers). Feng Shen is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (144 papers), Hepatocellular Carcinoma Treatment and Prognosis (120 papers) and Gallbladder and Bile Duct Disorders (76 papers). Feng Shen collaborates with scholars based in China, United States and Hong Kong. Feng Shen's co-authors include Mengchao Wu, Yong Xia, Kui Wang, Wan Yee Lau, Dong Wu, Tian Yang, Xuying Wan, Hugo P. Marques, Jun Li and Timothy M. Pawlik and has published in prestigious journals such as Advanced Materials, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Feng Shen

276 papers receiving 10.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy

2013 839 citations Yong Xia, Kui Wang et al. profile →
Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus–Related Hepatocellular Carcinoma Within the Milan Criteria

2015 458 citations Yong Xia, Kui Wang et al. profile →
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma

2018 357 citations Xin‐Fei Xu, Ya-Hao Zhou et al. profile →
Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription

2021 171 citations Qinjunjie Chen, Haibo Wang et al. Journal of Hepatology profile →

Peers

Countries citing papers authored by Feng Shen

Since Specialization

Citations

This map shows the geographic impact of Feng Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Shen more than expected).

Fields of papers citing papers by Feng Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Shen. The network helps show where Feng Shen may publish in the future.

Co-authorship network of co-authors of Feng Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Shen. A scholar is included among the top collaborators of Feng Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Shen. Feng Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ZEB1 silencing protects against ferroptosis and mitochondrial dysfunction in osteoarthritis by inhibiting HSPA5 expression 2025 ·Immunopharmacology and Immunotoxicology ·Jie Wan, Feng Shen, Jian Ding, Dong Ye	0
2	Predicting the complexity of minimally invasive liver resection for hepatocellular carcinoma using machine learning 2025 ·HPB ·Giovanni Catalano, Laura Alaimo, (unknown), Andrea Ruzzenente, (unknown), Luca Aldrighetti, Hugo P. Marques, François Cauchy, Vincent Lam, George A. Poultsides, Thomas J. Hugh, Irinel Popescu, Sorin Alexandrescu, (unknown), Minoru Kitago, (unknown), Ana Gleisner, Feng Shen, (unknown)	0
3	An outranking approach for multi-attribute group decision-making with interval-valued hesitant fuzzy information 2024 ·Engineering Applications of Artificial Intelligence ·Feng Shen, (unknown), (unknown), Zeshui Xu	2
4	Machine learning models including preoperative and postoperative albumin-bilirubin score: short-term outcomes among patients with hepatocellular carcinoma 2024 ·HPB ·Yutaka Endo, Diamantis I. Tsilimigras, Muhammad Musaab Munir, Selamawit Woldesenbet, Alfredo Guglielmi, Francesca Ratti, Hugo P. Marques, François Cauchy, Vincent Lam, George A. Poultsides, Minoru Kitago, Sorin Alexandrescu, Irinel Popescu, (unknown), Ana Gleisner, Tom Hugh, Luca Aldrighetti, Feng Shen, (unknown), Timothy M. Pawlik	5
5	A Sparse Antenna Array Synthesis Method for Road Positioning 2024 ·(unknown), (unknown), Yiming Lu, (unknown), Bo Lu, Feng Shen	0
6	Hydrogel Crosslinked with Nanoparticles for Prevention of Surgical Hemorrhage and Recurrence of Hepatocellular Carcinoma 2023 ·Advanced Science ·(unknown), Han Wu, Li Xu, (unknown), (unknown), Xin‐Fei Xu, (unknown), (unknown), Feng Shen, Dongsheng Huang, Tian Yang	13
7	Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies: ASAP score versus GALAD score 2023 ·Hepatobiliary & pancreatic diseases international ·Li‐Yang Sun, (unknown), Yong‐Kang Diao, (unknown), Zhuping Fan, (unknown), Huijun Li, (unknown), Ming-Da Wang, Timothy M. Pawlik, (unknown), Feng Shen, Guoyue Lv, Tian Yang	9
8	Diagnostic Performance of AFP, AFP-L3, or PIVKA-II for Hepatitis C Virus-Associated Hepatocellular Carcinoma: A Multicenter Analysis 2022 ·Journal of Clinical Medicine ·Siyu Liu, Li‐Yang Sun, Lan‐Qing Yao, Hong Zhu, Yong‐Kang Diao, Ming-Da Wang, Hao Xing, Wan Yee Lau, (unknown), Timothy M. Pawlik, Feng Shen, Min Xu, Xiangmin Tong, Tian Yang	23
9	Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription breakdown → 2021 ·Journal of Hepatology ·Qinjunjie Chen, Haibo Wang, Zheng Li, Fengwei Li, Leilei Liang, Yiran Zou, Hao Shen, Jun Li, Yong Xia, Zhangjun Cheng, Tian Yang, Kui Wang, Feng Shen	171
10	Long-term surgical outcomes of liver resection for hepatocellular carcinoma in patients with hepatitis B virus and hepatitis C virus co-infection: A multicenter observational study 2021 ·Annals of Hepato-Biliary-Pancreatic Surgery ·(unknown), Lei Liang, Chao Li, Han Wu, Hong Wang, Yingjian Liang, Ya-Hao Zhou, Wei‐Min Gu, (unknown), Wan Yee Lau, Timothy M. Pawlik, Yong‐Kang Diao, Qiuran Xu, Feng Shen, Chengwu Zhang, Dong‐Sheng Huang, Tian Yang	1
11	Major Hepatectomy in Elderly Patients with Large Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study 2020 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Liang Liu, Wu H, (unknown), (unknown), (unknown), (unknown), Li J, (unknown), Hong Wang, (unknown), (unknown), (unknown), (unknown), (unknown), Feng Shen, Tian Yang, (unknown)	1
12	A novel online prognostic tool to predict long‐term survival after liver resection for intrahepatic cholangiocarcinoma: The “metro‐ticket” paradigm 2019 ·Journal of Surgical Oncology ·Kota Sahara, Diamantis I. Tsilimigras, Rittal Mehta, Fabio Bagante, Alfredo Guglielmi, Luca Aldrighetti, Sorin Alexandrescu, Hugo P. Marques, Feng Shen, Bas Groot Koerkamp, Itaru Endo, Timothy M. Pawlik	19
13	Repeat hepatectomy for patients with early and late recurrence of hepatocellular carcinoma: A multicenter propensity score matching analysis 2019 ·Surgery ·(unknown), Li‐Yang Sun, Wentao Yan, Bing Quan, Lei Liang, Chao Li, Ya-Hao Zhou, Hong Wang, Jian‐Hong Zhong, Wei‐Min Gu, Ting‐Hao Chen, Ming-Da Wang, Han Wu, Timothy M. Pawlik, Wan Yee Lau, Mengchao Wu, Feng Shen, Tian Yang	35
14	Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma 2019 ·Journal of Gastrointestinal Surgery ·Stefan Buettner, David W.G. ten Cate, Fabio Bagante, Sorin Alexandrescu, Hugo P. Marques, Jorge Lamelas, Luca Aldrighetti, T. Clark Gamblin, Shishir K. Maithel, Carlo Pulitanò, Georgios Antonios Margonis, Matthew J. Weiss, Todd W. Bauer, Feng Shen, George A. Poultsides, J. Wallis Marsh, Jan N.M. IJzermans, Timothy M. Pawlik, Bas Groot Koerkamp	32
15	Discordance in prediction of prognosis among patients with intrahepatic cholangiocarcinoma: A preoperative vs postoperative perspective 2019 ·Journal of Surgical Oncology ·Amika Moro, Anghela Z. Paredes, Ayesha Farooq, Kota Sahara, Diamantis I. Tsilimigras, Rittal Mehta, Itaru Endo, Alfredo Guglielmi, Luca Aldrighetti, Sorin Alexandrescu, Hugo P. Marques, Feng Shen, Bas Groot Koerkamp, Kazunari Sasaki, Timothy M. Pawlik, (unknown)	5
16	Impact of microvascular invasion on clinical outcomes after curative‐intent resection for intrahepatic cholangiocarcinoma 2018 ·Journal of Surgical Oncology ·Liangshuo Hu, Matthew J. Weiss, Irinel Popescu, Hugo P. Marques, Luca Aldrighetti, Shishir K. Maithel, Carlo Pulitanò, Todd W. Bauer, Feng Shen, George A. Poultsides, Olivier Soubrane, Guillaume Martel, Bas Groot Koerkamp, Endo Itaru, Timothy M. Pawlik	38
17	The comprehensive surgical management for intrahepatic cholangiocarcinoma 2018 ·Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi ·Feng Shen, Han Zhang, Tian Yang	0
18	Preoperative prognostic nutritional index predicts survival of patients with intrahepatic cholangiocarcinoma after curative resection 2018 ·Journal of Surgical Oncology ·Özgür Akgül, Fabio Bagante, Griffin Olsen, Jordan M. Cloyd, Matthew J. Weiss, Katiuscha Merath, Sorin Alexandrescu, Hugo P. Marques, Luca Aldrighetti, Shishir K. Maithel, Carlo Pulitanò, Todd W. Bauer, Feng Shen, George A. Poultsides, Olivier Soubrane, Guillaume Martel, Bas Groot Koerkamp, Alfredo Guglielmi, Endo Itaru, Timothy M. Pawlik	34
19	Performance of prognostic scores and staging systems in predicting long‐term survival outcomes after surgery for intrahepatic cholangiocarcinoma 2017 ·Journal of Surgical Oncology ·Stefan Buettner, Boris Galjart, Jeroen L.A. van Vugt, Fabio Bagante, Sorin Alexandrescu, Hugo P. Marques, Jorge Lamelas, Luca Aldrighetti, T. Clark Gamblin, Shishir K. Maithel, Carlo Pulitanò, Georgios Antonios Margonis, Matthew J. Weiss, Todd W. Bauer, Feng Shen, George A. Poultsides, J. Wallis Marsh, Jan N.M. IJzermans, Bas Groot Koerkamp, Timothy M. Pawlik	40
20	STK33 promotes hepatocellular carcinoma through binding to c-Myc 2014 ·Gut ·Tian Yang, Bin Song, Jin Zhang, Guang-Shun Yang, Han Zhang, Weifeng Yu, Mengchao Wu, Jun‐Hua Lu, Feng Shen	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact